2Aboulafia DM.The epidemiologic,pathologic,and clinical features of AIDS-associated pulmonary Kaposi's sarcoma[J].Chest,2000,117(4):1128-1145.
3Goedert JJ,Charurat M,Blattner WA,et al.Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA[J].AIDS,2003,17(3):425-433.
4Engels EA,Biggar RJ,Marshall VA,et al.Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma[J].AIDS,2003,17 (12):1847-1851.
6Nakano K,Isegawa Y,Zou P,et al.Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-Ⅰ and vMIP-Ⅱ induce signal transduction and chemotaxis in monocytic cells[J].Arch Virol,2003,148(5):871-890.
7Stine JT,Wood C,Hill M,et al.KSHV-encoded CC chemokine vMIP-Ⅲ is a CCR4 agonist,stimulates angiogenesis,and selectively chemoattracts TH2 cells[J].Blood,2000,95(4):1151-1157.
8Chang Y,Cesanman F,Pressinms,et al.Identification of herpessins-like DNA sequence in AIDS-associnated kaposi sarcoma,Science,1994,266:1168.
